Glaucoma usually happens when extra fluid gradually increases pressure in the eye and causes irreversible damage to the optic ...

The latest announcement is out from Glaukos ( (GKOS) ).

Glaucoma prevalence appears higher than prior research has estimated, with approximately 4.22 million US adults affected.

Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and cut about 50% of its workforce.

Today there are more options than ever for managing migraine effectively. Find out what might work for you with this comprehensive guide to acute and preventive prescription drugs.

The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was evaluated in the LIGHTSITE III ...